Canos

Human-grade cancer monitoring.For your furry family.

Genetic health testing and cancer monitoring. Give your dog the power of precision care through blood genomics. Order now →

MORE TIME STARTS WITH KNOWING.

Cancer is the leading cause of death in dogs.

50%
of senior dogs die of cancer.
FDA
6M
dogs are diagnosed with cancer every year in the US.
National Cancer Institute

Early cancer detection has an 80% survival rate, compared to less than 20% for late-stage cancer.

Statistics from the American Cancer Society.

Canos provides state-of-the-art liquid biopsy testing for dogs.

Test covers genetic risk factors, epigenetic markers for aging, and active cancer signals.

Liquid biopsy is recommended in ASCO and ESMO guidelines and is already a standard tool in modern human cancer care.

Order in three steps.

Order a test
  1. Book your Canos test

    Choose the test that fits your dog. Book a visit online.

  2. Arrange a vet visit

    Choose a mobile vet, your own vet, or our group draw day.

  3. View your results

    Results ~1–2 weeks after your visit. Our team reviews the report with your vet.

PRECISION CARE, MADE PERSONAL.

Our liquid biopsy tests.

THE COMPLETE HEALTH PICTURE

Origin

Know their genetics. Understand their aging. Screen for cancer.

Regular price $699

Offer price $499

(vet visit fee included)

Order now

What’s included

  • Cell-free DNA analysis
  • 346 genetic health conditions
  • Traits and ancestry
  • Biological age & epigenetic markers
  • Cancer screening & active cancer signals
  • A comprehensive genomic health baseline
Learn more

STAY A STEP AHEAD OF RELAPSE

OncoTrack

Follow cancer through treatment, recovery and beyond.

Regular price $499

Offer price $199

Cancer relapse monitoring.

Book an appointment

What’s included

  • Cell-free DNA analysis
  • Methylation-based cancer monitoring
  • Minimal residual disease (MRD)
  • Treatment response tracking
  • Relapse monitoring
  • Report review with our team & your vet
Learn more

SCREEN FOR CANCER

Guardian

Multi-cancer screening from a simple blood draw.

Regular price $199

Offer price $99

Introductory offer · Save $100.

Order now

What’s included

  • Cell-free DNA analysis
  • Multi-cancer screening
  • Cancer screening report
Learn more

HUMAN CLINICAL PROGRESS

Already changing human cancer care.

Liquid biopsy already helps guide treatment decisions in human cancers.

ASCO2026

Informing treatment decisions

Blood tests can identify tumour changes that help doctors choose treatment.

Read the guideline ↗

FDA2026

Acting on residual disease

A blood test now helps identify patients for treatment after bladder cancer surgery.

Read the approval ↗
Explore the clinical evidence →

THE TEAM

The Canos co-founders working together in the laboratory

CO-FOUNDER

Dr Ming-Shan Tsai

Oxford DPhil in Zoology, with expertise spanning epigenetics, the genetic epidemiology of animal disease and biotechnology.

CO-FOUNDER

Dr Bin Li

PhD in Biomedical Engineering and former University of Oxford postdoctoral researcher in AI precision medicine, cancer imaging, pathology and spatial biology.


BACKED BYY CombinatorDEVELOPED BY SCIENTISTS FROM THEUniversity of OxfordIN COLLABORATION WITH SCIENTISTS FROM THERoyal Veterinary College (RVC)
Dog portrait in red and blue light

Human-grade cancer monitoring.

GET IN TOUCH

Contact Canos

Leave your email and we'll be in touch.

Blood draws are open.

Explore a genomic health baseline, cancer monitoring or a conversation with our team. Choose what brings you here.

Sign up for Canos

You can also leave a message, or simply your email, and we’ll get back to you.

My dog has been diagnosed with cancer and I need help.Explore the free OncoTrack trial →